CLINICAL_TRIALS
trial_result
· 2016-12-02
Clinical Trial Update: The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) [Phase 3]
Summary
A Phase 3 study evaluating roflumilast versus placebo in asthma patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED